Researchers have been excited about this new drug, a novel dual compound showing promising data in early trials for weight reduction . It acts by targeting two pathways : GLP-1 and GIP, these, when https://blanchelkiu792971.blogspothub.com/39588811/this-new-hope-for-size-loss